Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

Affiliations

¹ Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece.
² Pathology Department, Saint Savas Cancer Hospital, Athens, Greece.
³ Center for Medical Research, Eberhard-Karls Universität, Tübingen, Germany.
⁴ First Medical Oncology Clinic, Saint Savas Cancer Hospital, Athens, Greece.

^# Contributed equally.

Published Erratum

Sotirios P Fortis et al. J Immunother Cancer. 2017.

. 2017 May 30:5:48.

doi: 10.1186/s40425-017-0248-z. eCollection 2017.

¹ Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece.
² Pathology Department, Saint Savas Cancer Hospital, Athens, Greece.
³ Center for Medical Research, Eberhard-Karls Universität, Tübingen, Germany.
⁴ First Medical Oncology Clinic, Saint Savas Cancer Hospital, Athens, Greece.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.1186/s40425-017-0240-7.].

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer.
Fortis SP, Sofopoulos M, Sotiriadou NN, Haritos C, Vaxevanis CK, Anastasopoulou EA, Janssen N, Arnogiannaki N, Ardavanis A, Pawelec G, Perez SA, Baxevanis CN. Fortis SP, et al. J Immunother Cancer. 2017 Apr 18;5:39. doi: 10.1186/s40425-017-0240-7. eCollection 2017. J Immunother Cancer. 2017. PMID: 28428887 Free PMC article.

1. Fortis, S. P., Sofopoulos, M., Sotiriadou, N. N., Haritos, C., Vaxevanis, C. K., Anastasopoulou, E. A., … Baxevanis, C. N. Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer. J Immunother Cancer. 2017, 5, 39. http://doi.org/10.1186/s40425-017-0240-7. - PMC - PubMed